Discover key insights from Penumbra’s Q4 2024 earnings call: 12.9% revenue growth, strong thrombectomy performance, new product launches & 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback